¼¼°èÀÇ µ¿¸Æ Àý°³ Æó¼â ±â±â ½ÃÀå º¸°í¼­(2025³â)
Arteriotomy Closure Devices Global Market Report 2025
»óǰÄÚµå : 1716915
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,319,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,134,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,949,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

µ¿¸Æ Àý°³ Æó¼â ±â±â ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ °­·ÂÇÑ ¼ºÀåÀÌ Àü¸ÁµË´Ï´Ù. 2029³â ¿¬Æò±Õ ¼ºÀå·ü(CAGR)Àº 7.0%·Î, 22¾ï 6,000¸¸ ´Þ·¯·Î ¼ºÀåÇÕ´Ï´Ù. ¿¹Ãø ±â°£ Áß ¿¹»óµÇ´Â ¼ºÀåÀº Á׻󵿸ưæÈ­Áõ À¯º´·ü Áõ°¡, °ü»óµ¿¸ÆÁúȯ À¯º´·ü Áõ°¡, ȯÀÚÀÇ ¾ÈÀü°ú Æí¾ÈÇÔ¿¡ ´ëÇÑ °ü½É Áõ°¡, ½ÅÈï °æÁ¦±¹ÀÇ ÀÇ·á ÀÎÇÁ¶ó È®´ë, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µîÀÇ ¿äÀο¡ ±âÀÎÇÏ´Â °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÀÌ ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ÃÖ¼Òħ½ÀÀû ½Ã¼úÀÇ »ç¿ë, »ýüÈí¼ö¼º Àç·áÀÇ »ç¿ë, Æó¼â¼úÀÇ ÀÚµ¿È­, ½Ã¼ú È¿À²¼º Çâ»ó, ´õ Å« µ¿¸Æ õÀÚ¸¦ À§ÇÑ Æó¼â±â±¸ÀÇ ¹ßÀü µîÀÌ ÀÖ½À´Ï´Ù.

½ÉÇ÷°ü Áúȯ(CVDs)ÀÇ À¯º´·ü Áõ°¡´Â ÇâÈÄ ¼ö³â°£ µ¿¸Æ Àý°³ Æó¼â ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, CVD´Â ½ÉÀå°ú Ç÷°ü¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ´Ù¾çÇÑ ÁúȯÀ» Æ÷ÇÔÇϸç, CVD ¹ß»ý·ü Áõ°¡ÀÇ ÁÖ¿ä ¿øÀÎÀº ½Ä½À°ü Àå¾Ö, ¿îµ¿ ºÎÁ·, ºñ¸¸, °í·ÉÈ­ µî À§Çè ¿äÀÎ Áõ°¡·Î ÀÎÇÑ °ÍÀÔ´Ï´Ù. Áõ°¡ÀÔ´Ï´Ù. µ¿¸Æ Àý°³ Æó¼â ±â±â´Â µ¿¸Æ õÀÚ ºÎÀ§¸¦ È¿À²ÀûÀ¸·Î ¹ÐºÀÇϰí, ÇÕº´Áõ À§ÇèÀ» ÁÙÀ̰í, Ç÷°ü ¼ºÇü¼ú ¹× Ä«Å×ÅÍ Ä¡·á¿Í °°Àº Ä¡·á ÈÄ È¸º¹À» ÃËÁøÇÔÀ¸·Î½á ½ÉÇ÷°ü°è ½Ã¼ú¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2024³â 9¿ù ¿µ±¹¿¡ ±â¹ÝÀ» µÐ ½ÉÇ÷°ü ¿¬±¸ ±â°üÀÎ British Heart FoundationÀº ¿µ±¹¿¡¼­ ¾à 760¸¸ ¸íÀÌ ½ÉÀå ¹× ¼øÈ¯±â ÁúȯÀ» ¾Î°í ÀÖÀ¸¸ç, ±× Áß ³²¼º 400¸¸ ¸í, ¿©¼º 360¸¸ ¸íÀÌ ½ÉÀå ¹× ¼øÈ¯±â ÁúȯÀ» ¾Î°í ÀÖ´Ù°í º¸°íÇß½À´Ï´Ù. ÀÌ ¼öÄ¡´Â 2030³â±îÁö 100¸¸ ¸í ´õ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2040³â±îÁö ÃÖ´ë 200¸¸ ¸í±îÁö Áõ°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. °á°úÀûÀ¸·Î ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡°¡ µ¿¸ÆÀý°³ÆóÀåÄ¡ ½ÃÀå È®´ë¸¦ ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

µ¿¸Æ Àý°³ Æó¼â ±â±â ½ÃÀåÀÇ ÁÖ¿ä ¾÷üµéÀº ½Ã¼ú È¿À²¼º Çâ»ó, ȯÀÚ °á°ú °³¼±, ÃÖ¼Ò Ä§½ÀÀû Ç÷°ü Á¢±Ù ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇØ ±â¼ú Çõ½Å¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ¹Ìµåº¸¾î Á¤¸Æ Æó¼â ±â±â´Â Áß°£ Å©±âÀÇ Ä«Å×ÅÍ ¶Ç´Â ÇǺ¹À¸·Î Çü¼ºµÈ Á¤¸Æ Á¢±Ù ºÎÀ§¸¦ Æó¼âÇÏ¿© ÁöÇ÷À» µ½°í ÁßÀçÀû ½Ã¼ú ÈÄ È¯ÀÚÀÇ È¸º¹À» µ½´Â ÀÇ·á±â±âÀÔ´Ï´Ù. ¿¹¸¦ µé¾î 2024³â 6¿ù ¹Ì±¹ ÇコÄÉ¾î ±â¾÷ Haemonetics Corp.´Â VASCADE MVP XL ¹Ìµåº¸¾î Á¤¸Æ Æó¼â ÀåºñÀÎ VASCADE MVP XLÀ» Ãâ½ÃÇϸç VASCADE Á¦Ç°±ºÀ» È®ÀåÇß½À´Ï´Ù. ÀÌ Àåºñ´Â ³Ãµ¿ ÀýÁ¦¼ú°ú °°Àº ½Ã¼ú¿¡ ÀϹÝÀûÀ¸·Î »ç¿ëµÇ´Â µÎ²¨¿î Ä®Áý(¿Ü°æ 10-12F, ÃÖ´ë 15F)¿ëÀ¸·Î ¼³°èµÇ¾ú½À´Ï´Ù. Äݶó°ÕÀÇ ¾çÀ» 58% ´Ã¸®°í, ´õ Å« Á¢ÀÌ½Ä µð½ºÅ©¸¦ äÅÃÇÏ¿© ºü¸¥ ÁöÇ÷À» °¡´ÉÇÏ°Ô ÇÏ´Â ÀÌ Á¦Ç°Àº HaemoneticsÀÇ ¼Ò±¸°æ ¹× Áß±¸°æ Ç÷°ü Æó¼â ¼Ö·ç¼Ç Æ÷Æ®Æú¸®¿À¿¡ Ãß°¡µÇ¾î ÷´Ü Æó¼â ±â¼ú ºÐ¾ß¿¡¼­ HaemoneticsÀÇ ¸®´õ½ÊÀ» ´õ¿í °­Á¶ÇÕ´Ï´Ù. °­Á¶ÇÏ´Â Á¦Ç°ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ½ÃÀåÀÇ Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - °Å½Ã°æÁ¦ ½Ã³ª¸®¿À ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÇü Äڷγª¹ÙÀÌ·¯½ºÀÇ ¿µÇâ°ú ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ´ë±â¾÷°ú Çõ½ÅÀû ±â¾÷

Á¦32Àå ¼¼°èÀÇ ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÇÕº´°ú Àμö

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

An arteriotomy closure device (ACD) is a specialized medical tool intended to seal the puncture site in an artery after procedures such as catheterization or angiography. It helps achieve hemostasis by closing the artery, minimizing the risk of bleeding, and promoting a quicker recovery compared to manual compression. ACDs are frequently employed in minimally invasive vascular procedures to improve both patient safety and the efficiency of the procedure.

Arteriotomy closure devices primarily come in two types, active closure devices and passive closure devices. Active closure devices are used to close arterial puncture sites following medical procedures, employing mechanical or mechanical-hemostatic techniques to stop bleeding and support faster recovery. These devices are used in various procedures, including those involving femoral and radial arterial access, and are employed by a variety of healthcare settings, such as hospitals, outpatient care centers, and other medical facilities.

The arteriotomy closure devices market research report is one of a series of new reports from The Business Research Company that provides arteriotomy closure devices market statistics, including the arteriotomy closure devices industry global market size, regional shares, competitors with the arteriotomy closure devices market share, detailed arteriotomy closure devices market segments, market trends, and opportunities, and any further data you may need to thrive in the arteriotomy closure devices industry. This arteriotomy closure devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The arteriotomy closure devices market size has grown strongly in recent years. It will grow from $1.61 billion in 2024 to $1.73 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth observed in the past can be attributed to several factors, including the rising number of minimally invasive surgeries, the increasing prevalence of cardiovascular diseases, greater adoption of catheterization procedures, an aging population, and a growing demand for faster recovery times.

The arteriotomy closure devices market size is expected to see strong growth in the next few years. It will grow to $2.26 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The anticipated growth during the forecast period can be attributed to factors such as the increasing incidence of atherosclerosis, the rising prevalence of coronary artery diseases, a heightened focus on patient safety and comfort, expanding healthcare infrastructure in developing economies, and a growing demand for ambulatory surgical centers. Key trends for this period include the use of minimally invasive techniques, the adoption of bioresorbable materials, the incorporation of automation in closure procedures, improvements in procedural efficiency, and advancements in closure devices for larger arterial punctures.

The rising prevalence of cardiovascular diseases (CVDs) is expected to drive the growth of the arteriotomy closure devices market in the coming years. CVDs encompass a range of disorders that impact the heart and blood vessels. The growing incidence of CVDs is primarily due to increasing risk factors such as poor diets, lack of physical activity, obesity, and an aging population. Arteriotomy closure devices play a critical role in cardiovascular procedures by efficiently sealing arterial puncture sites, reducing the risk of complications, and enhancing recovery after treatments such as angioplasties and catheterizations. For example, in September 2024, the British Heart Foundation, a UK-based cardiovascular research organization, reported that around 7.6 million people in the UK are affected by heart and circulatory diseases, including 4 million men and 3.6 million women. This number is expected to rise by an additional 1 million by 2030 and may increase by up to 2 million by 2040. As a result, the growing prevalence of cardiovascular diseases is driving the expansion of the arteriotomy closure devices market.

Leading companies in the arteriotomy closure devices market are focusing on innovation to improve procedural efficiency, enhance patient outcomes, and address the growing demand for minimally invasive vascular access solutions. A mid-bore venous closure device is a medical instrument designed to close venous access sites created by medium-sized catheters or sheaths, helping with hemostasis and supporting patient recovery after interventional procedures. For example, in June 2024, Haemonetics Corp, a US-based healthcare firm, expanded its VASCADE product line by introducing the VASCADE MVP XL mid-bore venous closure device. This device is designed for larger sheaths (10-12F, up to 15F outer diameter) commonly used in procedures such as cryoablation. It features 58% more collagen and a bigger collapsible disc to facilitate rapid hemostasis. This addition to Haemonetics' portfolio of small- and mid-bore vascular closure solutions highlights the company's leadership in advanced closure technology.

In February 2022, Boston Scientific Corporation, a US-based company specializing in medical technology, acquired Baylis Medical Company Inc. for $1.75 billion. This acquisition is intended to strengthen Boston Scientific's product offerings in electrophysiology and structural heart. It also incorporates Baylis Medical's cutting-edge transseptal access solutions. Baylis Medical Company Inc., based in Canada, is a medical device company known for its innovative solutions in cardiovascular procedures.

Major players in the arteriotomy closure devices market are Cardinal Health Inc., Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Terumo Corporation, Teleflex Incorporated, Cook Medical Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd., Haemonetics Corporation, Cordis Corporation, Asahi Intecc Co. Ltd., LeMaitre Vascular Inc., Cardiva Medical Inc., AccessClosure Inc., Vasorum Limited, Invamed (Pty) Ltd., Artio Medical Inc., SUTUREGARD Medical Inc., and Vivasure Medical.

North America was the largest region in the arteriotomy closure devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in arteriotomy closure devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the arteriotomy closure devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The arteriotomy closure devices market consists of sales of angiograms, catheterizations, and other interventional surgeries. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Arteriotomy Closure Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on arteriotomy closure devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for arteriotomy closure devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The arteriotomy closure devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Arteriotomy Closure Devices Market Characteristics

3. Arteriotomy Closure Devices Market Trends And Strategies

4. Arteriotomy Closure Devices Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Arteriotomy Closure Devices Growth Analysis And Strategic Analysis Framework

6. Arteriotomy Closure Devices Market Segmentation

7. Arteriotomy Closure Devices Market Regional And Country Analysis

8. Asia-Pacific Arteriotomy Closure Devices Market

9. China Arteriotomy Closure Devices Market

10. India Arteriotomy Closure Devices Market

11. Japan Arteriotomy Closure Devices Market

12. Australia Arteriotomy Closure Devices Market

13. Indonesia Arteriotomy Closure Devices Market

14. South Korea Arteriotomy Closure Devices Market

15. Western Europe Arteriotomy Closure Devices Market

16. UK Arteriotomy Closure Devices Market

17. Germany Arteriotomy Closure Devices Market

18. France Arteriotomy Closure Devices Market

19. Italy Arteriotomy Closure Devices Market

20. Spain Arteriotomy Closure Devices Market

21. Eastern Europe Arteriotomy Closure Devices Market

22. Russia Arteriotomy Closure Devices Market

23. North America Arteriotomy Closure Devices Market

24. USA Arteriotomy Closure Devices Market

25. Canada Arteriotomy Closure Devices Market

26. South America Arteriotomy Closure Devices Market

27. Brazil Arteriotomy Closure Devices Market

28. Middle East Arteriotomy Closure Devices Market

29. Africa Arteriotomy Closure Devices Market

30. Arteriotomy Closure Devices Market Competitive Landscape And Company Profiles

31. Arteriotomy Closure Devices Market Other Major And Innovative Companies

32. Global Arteriotomy Closure Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Arteriotomy Closure Devices Market

34. Recent Developments In The Arteriotomy Closure Devices Market

35. Arteriotomy Closure Devices Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â